Quadrant Biosciences Inc

📍 United States🗓 Founded 2015👥 88 employees💰 Last funded 2021
Quadrant Biosciences is an epigenetic diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary advancements in the early detection of autism spectrum disorder, Parkinson’s disease, and mTBI, through the application of the Clarifi® epigenetic diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions. In March 2020, we made the decision to pivot and allocate some of our resources to directly address the pandemic. By leveraging our expertise in RNA analysis, we have been able to be part of three exciting COVID-19 projects to aid in the detection of COVID-19 in individuals and communities across the U.S. In September 2020, The Clarifi COVID-19 Test Kit obtained Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be used for the diagnosis fo SARS-CoV-2.
8
Total investors
0
Early stage
4
Mid stage
4
Late stage
2015
Founded
Investor geography3 countries
United States
5
Indonesia
2
Italy
1
Investor activity2016–2021 · investors recorded per year
20161201812020520211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Quadrant Biosciences Inc?
Quadrant Biosciences Inc has 8 investors on record on gritt.io, 4 mid-stage and 4 late-stage investors.
When did Quadrant Biosciences Inc last raise funding?
The most recent investment in Quadrant Biosciences Inc recorded on gritt.io was in 2021.
When was Quadrant Biosciences Inc founded?
Quadrant Biosciences Inc was founded in 2015.
What industry is Quadrant Biosciences Inc in?
Quadrant Biosciences Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Quadrant Biosciences Inc based?
Quadrant Biosciences Inc is headquartered in United States.